4’-alpha-C-Allyl-2’,3’-bis(O-t-butyldimethylsilyl) uridine

• UNSPSC Description:

  4’-alpha-C-Allyl-2’,3’-bis(O-t-butyldimethylsilyl) uridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/4-alpha-c-allyl-2-3-bis-o-t-butyldimethylsilyl-uridine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C=C1)NC(N1[C@@H]2O[C@@](CO)(CC=C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)=O

• Molecular Weight:

  512.79

• References & Citations:

  [1]Connolly GP, et al. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20(5):218-25.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  512184-18-8